SageBiogen

A sign marks a Biogen facility in Boston, U.S., March 9, 2020. REUTERS/Brian Snyder Register now for FREE unlimited access to Reuters.com Register June 1 (Reuters) – Sage Therapeutics Inc (SAGE.O) and Biogen’s (BIIB.O) experimental drug improved symptoms of postpartum depression after 15 days in a late-stage study, the companies […]